BACKGROUND Takotsubo syndrome (TTS) is characterized by an acute left ventricular dysfunction and is associated
The syndrome is often triggered by emotional or physical stressors (3, 4) . TTS is life-threatening, with 22% of patients experiencing serious in-hospital complications, such as ventricular tachycardia, cardiogenic shock, or death (2) . Even long-term followup is not completely benign, as the rate of recurrence in TTS is 2%, and the major adverse cardiac and cerebrovascular event rate is 10% per patient-year (2).
Several hypotheses have been proposed to describe the pathomechanisms (5,6); however, the exact mechanism leading to TTS is still under debate. Detailed mechanistic studies are difficult to perform due to the lack of a reliable TTS model that translates to humans. Adrenergic overstimulation seems to play an important role in TTS, and it has been suggested that heart function can be damaged by excessive catecholamine release (7) . This indicates that a normally protective mechanism might fail in these subjects.
Several familial cases of TTS have been described in published reports (8) , although it is unclear to date whether this disease has a genetic component. Small studies in individual patients have reported an association between TTS and several genes, including Bcl-2-associated athanogene 3 (BAG3) (9) .
A big hurdle in understanding the molecular and cellular physiology of TTS has been the lack of human cardiomyocyte (CM) culture models from patients with TTS. The availability of methods to generate induced pluripotent stem cells (iPSCs) and to direct their differentiation toward a CM phenotype overcomes this hurdle by enabling the creation of patientspecific TTS disease models. iPSC-CMs have been especially widely used to study hereditary cardiac conditions in vitro, including arrhythmic disorders or cardiomyopathies, with a robust correlation to predicted phenotypes (10) . A genetic predisposition, although suggested (8) , is less well established for TTS. We tested the hypothesis that TTS-iPSC-CMs phenocopy the disease in the dish, and thus allow for mechanistic studies to facilitate the development of novel therapeutic and protective strategies in patients with TTS.
METHODS
Details are available in the Online Appendix. Table 1 ) (11) . A total of 4 healthy donors were used as control subjects in this study (Online Table 1 ).
One healthy control subject (control 1) is a 52-year-old postmenopausal woman. Two further control subjects are 25-year-old women (controls 2 and 3).
One anonymous healthy woman control subject (FB2) was characterized and described in our previous study (12) .
REPROGRAMMING OF SOMATIC CELLS INTO iPSCs.
Fibroblasts (TTS patients 1, 2, 5 and 8; controls 2 and 3) or peripheral blood cells (control 1) were reprogrammed using nonintegrating systems, and highquality iPSC clones were expanded. Cell lines were named 1-TTS-1, 1-TTS-2, 2-TTS-1, 5-TTS-1, 5-TTS-2, 8-TTS-1, and 8-TTS-2 from TTS patients 1, 2, 5, and 8;
and 1-C-1, 1-C-2, 2-C-1, 2-C-2, 3-C-1, and 3-C-2 for cell lines from healthy controls 1, 2, and 3 (Online Table 2 ).
CHARACTERIZATION OF iPSC-CMs. iPSCs were differentiated into CMs using Wnt modulation (13) and subsequent metabolic selection (14) . iPSC-CMs Nikolaev, Guan, Tiburcy, Zimmermann, and Wollnik), the Bundesministerium für Bildung und Forschung grant e:Bio-Modul II-Verbundprojekt: CaRNAtion (031L0075C to Drs. Streckfuss-Bömeke, Guan, and Hasenfuss), and the Foundation for Cardiovascular Research-Zurich Heart House, Switzerland. Dr. Ghadri has received a research grant "Filling the Gap" from the University of Zurich. Dr. Meder has received research support from Siemens AG. Dr. Zimmermann is co-founder of and has served as a scientific advisor for Myriamed GmbH. Dr. Hasenfuss has served as a consultant for Servier, Impulse Dynamics, Novartis, and Corvia; has served as co-principal investigator for Impulse Dynamics; has received honoraria for presentations from Servier, Novartis, AstraZeneca, and Vifor Pharma; and has served as a principal investigator for Corvia. All other authors have reported that Primers and antibodies used in this study are provided in Online Tables 3 and 4 .
RESULTS iPSCs GENERATED FROM PATIENTS WITH TTS SHOW
PLURIPOTENT CHARACTERISTICS AND CAN BE DIFFERENTIATED INTO FUNCTIONAL CMs. The iPSC lines generated for this study showed typical human pluripotent stem cell characteristics (Online Figure 1 ).
No differences in differentiation efficiency were observed between control and TTS-iPSCs. Using a directed differentiation protocol, we achieved a cardiomyocyte purity of >85% at culture day 60 (determined by flow cytometry analysis for cardiac troponin T [cTNT]) ( Figure 1A) . The CM cultures derived from both control-and TTS-iPSCs expressed high levels of cardiac-specific genes, such as a-actinin (ACTN2), a-myosin heavy chain (a-MHC), b-myosin heavy chain (ß-MHC), and cTNT at the mRNA level, and show a-actinin-, and cTNT-positive sarcomeric structural features ( Figures 1B and 1C , Online Video 1).
BRIEF CATECHOLAMINE TREATMENT AS AN INDUCER OF
STRESS. Exposure to high levels of catecholamines has been implicated in TTS (7) . We therefore aimed to induce a TTS-related phenotype in iPSC-CMs after exposure to catecholamines (Iso [100 nmol/l to 5 mmol/l], and Epi [100 nmol/l to 500 mmol/l]), as described previously (6, 7) . These experimental conditions did not result in an irregular sarcomeric structure ( Figure 1C ) or apoptosis as analyzed by annexin V/propidium iodide (PI) flow cytometric assay ( Figure 1D ). We then analyzed the expression of cardiac stress-related genes in iPSC-CMs, including NR4A1, by quantitative PCR. NR4A1 is strongly increased for all tested concentrations of Iso and Epi in both TTS-iPSC-CMs (16-to 19-fold for Iso; 13-to 30-fold for Epi) and control-iPSC-CMs (10-to 8-fold for Iso; 13-to 27-fold for Epi) ( Figure 1E ). After Iso stimulation, NR4A1 expression was significantly greater in TTS-iPSC-CMs than in control-iPSC-CMs.
These changes in NR4A1 expression were reversed after a 3-week catecholamine washout period ( Figure 1E , Epi rec). (Figures 2A and 2C ).
There was no additional effect at greater Iso levels (1.18-fold increase at 1 mmol/l Iso) (Figures 2A and 2C ).
In contrast, TTS CMs reacted to higher Iso concentrations of 1 mmol/l (1.55-fold; p ¼ 0.0621) and 1 mmol/l (1.98; p ¼ 0.0029) with a further significant increase in the CFP/YFP ratio, and therefore higher cytoplasmic cAMP levels in TTS-CMs relative to control iPSC-CMs ( Figures 2B and 2C ). This suggests a higher catecholamine-dependent dynamic range in TTS-iPSC-CMs. As cAMP can be synthesized at low rates under basal conditions, we pretreated the iPSCCMs with the unselective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthin (IBMX) in the absence of Iso. Under these experimental conditions, we detected no significant difference in FRET response in control and TTS-iPSC-CMs (Online Figures 2A to 2C ). This suggests similar basal cytoplasmic cAMP levels in iPSC-CMs of patients with TTS compared to control subjects.
To further investigate b-adrenergic signaling in TTS-iPSC-CMs, we analyzed the activation of PKA by phosphorylation of its target sites RYR2-2808, PLN-S16, TNI-S23/24, and Cav1.2-S1928. Western blots of Iso-and Epi-treated iPSC-CMs showed significantly greater phosphorylation of PLN-S16, RYR2-S2808, and Cav1.2-S1928 in TTS-iPSC-CMs after catecholamine treatment ( Figures 2D to 2G ). TNI-S23/24 exhibited a trend toward enhanced phosphorylation
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in TTS compared with control iPSC-CMs ( Figure 2H ).
Importantly, we found a significant 5.7-fold increase of PLN-S16 phosphorylation at a basal level without catecholamine treatment in TTS-iPSC-CMs ( Figure 2E , Online Figures 2D and 2E ). An additional Iso treatment resulted in a 13-(100 nmol/l) or 14-fold (5 mmol/l) greater absolute phosphorylation in TTS compared with control subjects (Figures 2D and 2E ).
After normalization, we found no significant differences in phosphorylation between TTS and control subjects (Online Figure 3C) . PKA-specific RYR2-S2808
showed a 3.3-to 6.4-fold greater phosphorylation and Cav1.2-S1928 showed a 3.3-to 3.7-fold greater phos- 
ALTERED FUNCTIONALITY OF CALCIUM HOMEOSTASIS AND FORCE DEVELOPMENT IN PATIENTS WITH TTS.
Due to Iso-dependent alterations in cAMP levels, PKA activity, and electrical activity in TTS, we sought to investigate calcium kinetics in iPSC-CMs. We IPSC-CMs were treated with catecholamines for 2 h. Control:
. Mean AE SEM, *p < 0.05; **p < 0.01; ***p < 0.001 significant differences by 1-way ANOVA for each group (control, TTS) combined with the Student t test. Cells were counterstained with 4ʹ,6-diamidino-2-phenylindole for nuclear localization (blue) (C). GAPDH was used as internal control
iPSC ¼ induced pluripotent stem cell; Iso ¼ isoprenaline; mRNA ¼ messenger ribonucleic acid; NR4A1 ¼ nuclear receptor subfamily 4 group A member 1; SEM ¼ standard error of the mean; TTS ¼ Takotsubo syndrome.
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A U G U S T 2 2 , 2 0 1 7 : 9 7 5 -9 1 and patients with TTS (1-TTS). (E) Quantified absolute PLN-S16 phosphorylation is increased in TTS patients in comparison with control cells (control:
Quantified and normalized RyR2-S2808-, Cav1.2-S1928-, and TNI-S23/24 phosphorylation is increased in patients with TTS in comparison with control cells (n ¼ 3 to 7 differentiation experiments; for details see Online Table 5 ) upon Iso. Data are presented as mean AE SEM of the ratio of normalized phosphorylated protein over total protein. * or §p < 0.05; ** or § §p < 0.01; ***p < 0.001 significant differences by multiple Student t tests and the Sidak-Bonferroni method. §Significant differences of other abbreviations as in Figure 1 .
Additionally, increasing Iso-dependent FRET responses under ICI or CGP antagonism are observed in TTS (Online Figures 7D to 7F) . Diego, California) and the sarcomeric protein a-actinin ( Figure 5F ). Confocal microscopy showed that control cells treated with high Iso dosages showed a significant decrease in mitochondrial area, but a regular a-actinin-positive sarcomeric structure ( Figures 5E and 5F ).
In contrast, iPSC-CMs of patients with TTS already revealed a significantly decreased mitochondrial area at basal conditions without Iso treatment (Figures 5E and 5F).
GENETIC-BASED CARDIAC DYSFUNCTION IN PATIENTS
WITH TTS. We performed whole-exome sequencing (WES) on deoxyribonucleic acid extracted from primary skin fibroblasts of 4 patients with TTS. Because Borchert et al.
Mechanisms of Takotsubo Syndrome (17), which we found to be expressed at higher abundance in TTS ( Figure 5C ). These data argue for NR4A1-dependent crosstalk between the b-AR signaling and lipid metabolism, and suggest NR4A1
as a potential therapeutic target in TTS. However, the exact functional role of NR4A1 in b-AR signaling and lipid homeostasis in the TTS heart remains to be elucidated.
The FRET measurements showed a higher cAMP response to increasing catecholamine levels in TTSiPSC-CMs compared with control cells ( Figure 2C ).
This may result in a cAMP-dependent increased activation of PKA and subsequent specific phosphorylation of its cellular targets, including RYR2-2808, PLN-S16, TNI-S23/24, and Cav1.2-S1928
( Figures 2D to 2H) . Besides cAMP levels, Isodependent beating frequency also shows a larger dynamic range in TTS compared with control subjects ( Figure 2J ). The combined monolayer data suggests increased susceptibility to catecholamines under intensive stress conditions in patients with TTS. This conclusion is strengthened by our EHM data, which demonstrated enhanced sensitivity to Iso in TTS ( Figure 3D Borchert et al.
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